MD3222F1 - Method of endometrial cancer diagnosis - Google Patents
Method of endometrial cancer diagnosisInfo
- Publication number
- MD3222F1 MD3222F1 MDA20060093A MD20060093A MD3222F1 MD 3222 F1 MD3222 F1 MD 3222F1 MD A20060093 A MDA20060093 A MD A20060093A MD 20060093 A MD20060093 A MD 20060093A MD 3222 F1 MD3222 F1 MD 3222F1
- Authority
- MD
- Moldova
- Prior art keywords
- endometrial cancer
- diagnosis
- endometrial
- cancer diagnosis
- concentration
- Prior art date
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Inventia se refera la medicina, in special la oncologie si poate fi utilizata pentru diagnosticul neinvaziv precoce si pentru confirmarea diagnosticului de cancer endometrial. Esenta inventiei constain determinarea concentratiei de ARN mesager al triptofanhidroxilazei-1 in tesuturile endometrial si miometrial, si in cazul cand in tesutul endometrial concentratia este de 2…100 ori mai mare, se stabileste diagnosticul de cancer endometrial. Rezultatul inventiei consta in posibilitatea diagnosticarii precoce diferentiate a cancerului endometrialpentru stabilirea metodei eficiente de tratament pre- si postoperator.The invention relates to medicine, especially oncology and can be used for early noninvasive diagnosis and for confirming the diagnosis of endometrial cancer. The essence of the invention consists in determining the concentration of messenger RNA of tryptophanhydroxylase-1 in the endometrial and myometrial tissues, and if in the endometrial tissue the concentration is 2 ... 100 times higher, the diagnosis of endometrial cancer is established. The result of the invention consists in the possibility of early differential diagnosis of endometrial cancer for establishing the effective method of pre- and post-operative treatment.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20060093A MD3222G2 (en) | 2006-03-22 | 2006-03-22 | Method of endometrial cancer diagnosis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20060093A MD3222G2 (en) | 2006-03-22 | 2006-03-22 | Method of endometrial cancer diagnosis |
Publications (2)
Publication Number | Publication Date |
---|---|
MD3222F1 true MD3222F1 (en) | 2007-01-31 |
MD3222G2 MD3222G2 (en) | 2007-08-31 |
Family
ID=37776647
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDA20060093A MD3222G2 (en) | 2006-03-22 | 2006-03-22 | Method of endometrial cancer diagnosis |
Country Status (1)
Country | Link |
---|---|
MD (1) | MD3222G2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD3499G2 (en) * | 2007-10-12 | 2008-09-30 | Общественное Медико-Санитарное Учреждение Онкологический Институт | Method of differentiated treatment of endometrial cancer |
MD492Z (en) * | 2011-08-17 | 2012-10-31 | Лорена МЕДНИКОВ | Method for determining the spread of intestinal type gastric cancer |
-
2006
- 2006-03-22 MD MDA20060093A patent/MD3222G2/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MD3222G2 (en) | 2007-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LTPA2016034I1 (en) | Bruton tyrosine kinase inhibitors | |
PH12017502286A1 (en) | Monoclonal antibodies against tissue factor pathway by inhibitor (tfpi) | |
HUP0302332A2 (en) | Gene detection method for improving the likelihood of an effective response to an erbb antagoist cancer therapy | |
NO20064676L (en) | Pharmaceutical salts of 3-O- (3'3'-dimethylsuccinyl) betulinic acid | |
NZ593474A (en) | Compositions and methods for treatment of celiac disease | |
HK1202561A1 (en) | Antibody bound to anionic phospholipid and aminophospholipid, therapeutic and imaging uses thereof | |
MX2011010390A (en) | Polymer-agent conjugates, particles, compositions, and related methods of use. | |
MA29615B1 (en) | PREPARATIONS AND METHODS FOR DIAGNOSING AND TREATING A TUMOR | |
EA200900203A1 (en) | ELECTORAL MODULATORS OF ANDROGENS RECEPTOR, THEIR ANALOGUES, DERIVATIVES AND APPLICATIONS | |
MX2007011545A (en) | Combinations for the treatment of cancer comprising anti-egfr antibody and vegfr inhibitors. | |
EA200970953A1 (en) | SPECIFIC INHIBITORS PDGFRβ | |
DE602005026866D1 (en) | USE OF THREE-DIMENSIONAL CULTURED TISSUE FOR THE TREATMENT OF CONGESTIVE HEART FAILURE | |
SG158919A1 (en) | Constructs binding to phosphatidylserine and their use in disease treatment | |
RS20150135A1 (en) | Treatment with anti-vegf antibodies | |
CO5660287A2 (en) | DERIVATIVES OF TETRAHYDROCARBAZOL AND ITS PHARMACEUTICAL USE | |
EP2987807A3 (en) | Antibodies recognising phospho-tau | |
DE602005018043D1 (en) | LIPOSOMAL FORMULATIONS WITH DIHYDROSPHENOMYLININ AND METHOD FOR THEIR USE | |
EA201001695A1 (en) | APPLICATION OF EPOTHILON D FOR THE TREATMENT OF DISEASES ASSOCIATED WITH TAU-PROTEIN | |
BRPI0908635B8 (en) | compound and/or a pharmaceutically acceptable salt thereof and pharmaceutical composition | |
EP2687235A3 (en) | Methods for production and use of substance-loaded erythrocytes (S-LES) for observation and treatment of microvascular hemodynamics | |
SE0300098D0 (en) | Use of cyclin D1 inhibitors | |
MA35281B1 (en) | Assay and administration of anti-erbb3 antibodies in combination with paclitaxel for the treatment of gynecological cancers | |
MX2011010911A (en) | Combination therapy using an anti-egfr agent(s) and igf-1r specific inhibitors. | |
MD3222F1 (en) | Method of endometrial cancer diagnosis | |
AU2001235761A1 (en) | Diagnosis of breast cancer using bcmp-11 as marker |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG4A | Patent for invention issued | ||
KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
MM4A | Patent for invention definitely lapsed due to non-payment of fees |